Sun Pharma inks pact with LIB Therapeutics to sell LDL-C drug
Sun Pharmaceutical Industries and LIB Therapeutics Inc on Monday announced an exclusive licensing agreement granting the Indian drug maker rights to commercialise and manufacture lerodalcibep worldwide, excluding the U.S. and China. The agreement establishes a new growth platform for it in a large and rapidly expanding market, Sun Pharma said. IQVIA numbers show the PCSK9…
Read More “Sun Pharma inks pact with LIB Therapeutics to sell LDL-C drug” »